Patent · US Expired

Amylin agonist peptides and uses therefor

US6610824B2 · kind B2 · utility

10Cited by
21References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 6, 1999
Grant dateAug 26, 2003
Priority date
Expiry dateFeb 26, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Agonist analogs of amylin and related pharmaceutical compositions, and methods of treatment of diabetes and other insulin-requiring states, as well as methods of treatment of hypoglycemia, are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.